H2AP
gene geneOn this page
Also known as HIP17
Summary
H2AP (H2A.P histone, HGNC:18417) is a protein-coding gene on chromosome Xp11.4, encoding Huntingtin-interacting protein M (O75409).
This gene encodes a protein shown to interact with huntingtin, which contains an expanded polyglutamine tract in individuals with Huntington’s disease (PMID: 9700202).
Source: NCBI Gene 25763 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 20 total — 1 pathogenic
- MANE Select transcript:
NM_012274
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18417 |
| Approved symbol | H2AP |
| Name | H2A.P histone |
| Location | Xp11.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HIP17 |
| Ensembl gene | ENSG00000187516 |
| Ensembl biotype | protein_coding |
| Entrez | 25763 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000341016
RefSeq mRNA: 1 — MANE Select: NM_012274
NM_012274
CCDS: CCDS43929
Canonical transcript exons
ENST00000341016 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001383093 | 37990779 | 37991314 |
Expression profiles
Bgee: expression breadth broad, 49 present calls, max score 95.50.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0405 / max 32.4781, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 195928 | 0.0405 | 4 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.50 | gold quality |
| sperm | CL:0000019 | 91.14 | gold quality |
| left testis | UBERON:0004533 | 90.45 | gold quality |
| right testis | UBERON:0004534 | 89.89 | gold quality |
| male germ cell | CL:0000015 | 88.12 | gold quality |
| testis | UBERON:0000473 | 87.18 | gold quality |
| frontal pole | UBERON:0002795 | 60.41 | gold quality |
| adult organism | UBERON:0007023 | 60.36 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 60.23 | gold quality |
| amniotic fluid | UBERON:0000173 | 60.17 | gold quality |
| paraflocculus | UBERON:0005351 | 59.90 | gold quality |
| endometrium epithelium | UBERON:0004811 | 56.90 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.84 | gold quality |
| thymus | UBERON:0002370 | 50.19 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.06 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 49.61 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.57 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cerebellar vermis | UBERON:0004720 | 49.25 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.47 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.40 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting H2AP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-501-5P | 98.77 | 68.88 | 1328 |
| HSA-MIR-6811-3P | 98.62 | 66.54 | 944 |
| HSA-MIR-6787-3P | 97.75 | 66.17 | 1233 |
| HSA-MIR-6500-3P | 97.42 | 67.20 | 867 |
| HSA-MIR-490-5P | 96.75 | 65.81 | 661 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | H2ap | ENSMUSG00000040456 |
| rattus_norvegicus | H2ap | ENSRNOG00000089464 |
Protein
Protein identifiers
Huntingtin-interacting protein M — O75409 (reviewed: O75409)
Alternative names: Histone H2A.P, Huntingtin yeast partner M
All UniProt accessions (1): O75409
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. May interact with the N-terminus of HD.
RefSeq proteins (1): NP_036406* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009072 | Histone-fold | Homologous_superfamily |
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75409-F1 | 66.02 | 0.14 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOCC_PROTEIN_DNA_COMPLEX, GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MODULE_49, DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP, chrXp11, GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION, GOCC_NUCLEOSOME
GO Biological Process (1): heterochromatin formation (GO:0031507)
GO Molecular Function (3): structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982), protein binding (GO:0005515)
GO Cellular Component (2): nucleosome (GO:0000786), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin | 2 |
| cellular component assembly | 1 |
| heterochromatin boundary formation | 1 |
| negative regulation of gene expression, epigenetic | 1 |
| heterochromatin organization | 1 |
| structural molecule activity | 1 |
| protein dimerization activity | 1 |
| binding | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
962 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H2AP | TP53BP1 | Q12888 | 549 |
| H2AP | FAM237B | A0A1B0GVD1 | 514 |
| H2AP | HTT | P42858 | 485 |
| H2AP | FAM171B | Q6P995 | 481 |
| H2AP | A0A0A6YYL1 | A0A0A6YYL1 | 445 |
| H2AP | ZNF839 | A8K0R7 | 426 |
| H2AP | H2AB1 | P0C5Y9 | 373 |
| H2AP | TMEM243 | Q9BU79 | 350 |
| H2AP | GDE1 | Q9NZC3 | 340 |
| H2AP | SH2D4A | Q9H788 | 327 |
| H2AP | GPATCH1 | Q9BRR8 | 322 |
| H2AP | RAD9A | Q99638 | 320 |
| H2AP | RIPPLY3 | P57055 | 305 |
| H2AP | H1-7 | Q75WM6 | 303 |
| H2AP | H2AC20 | Q16777 | 299 |
| H2AP | H2AC19 | P20670 | 299 |
IntAct
78 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| H2AP | MYOG | psi-mi:“MI:0915”(physical association) | 0.720 |
| CEP44 | H2AP | psi-mi:“MI:0915”(physical association) | 0.720 |
| H2AP | CEP44 | psi-mi:“MI:0915”(physical association) | 0.720 |
| H2AP | SIX1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| H2AP | CENPH | psi-mi:“MI:0915”(physical association) | 0.670 |
| H2AP | HTT | psi-mi:“MI:0915”(physical association) | 0.670 |
| H2AP | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H2AP | psi-mi:“MI:0915”(physical association) | 0.560 | |
| MAGEB4 | H2AP | psi-mi:“MI:0915”(physical association) | 0.560 |
| H2AP | APOE | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (87): HYPM (Two-hybrid), CEP44 (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), HYPM (Two-hybrid), USP28 (Affinity Capture-MS), RAB5A (Affinity Capture-MS), ZFPL1 (Affinity Capture-MS), NCAPG (Affinity Capture-MS)
ESM2 similar proteins: A3RM20, A4QE81, A6ZMG4, A8C8J5, B2IUW7, B3LLZ8, B7KF62, C7GWA2, C8ZEW0, O66665, O75409, O94293, P02892, P03872, P04376, P09297, P18571, P21299, P26654, P30890, P38302, P40155, Q04438, Q06091, Q07FI4, Q09223, Q0GBX8, Q22058, Q28103, Q289M6, Q2Y2M2, Q3MBJ9, Q4R717, Q5GSP9, Q5H943, Q5WFM7, Q6C070, Q6WB97, Q6X1D3, Q6ZQV5
Diamond homologs: O75409, Q9CR04, A0A0D2UG83, A0A3B3IU63, A5DXS8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 599548 | NM_012274.2(H2AP):c.321_322del (p.Phe107fs) | Pathogenic |
SpliceAI
210 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:37990854:GAACT:G | donor_gain | 0.8700 |
| X:37990859:G:GG | donor_gain | 0.7900 |
| X:37990987:A:AG | donor_gain | 0.7700 |
| X:37990987:A:G | donor_gain | 0.7500 |
| X:37990918:GTCCC:G | donor_gain | 0.7400 |
| X:37990919:TCCCT:T | donor_gain | 0.7400 |
| X:37991300:G:GT | donor_gain | 0.7400 |
| X:37990960:G:GT | donor_gain | 0.6800 |
| X:37991069:G:GG | donor_gain | 0.6800 |
| X:37990964:TCCA:T | donor_gain | 0.6700 |
| X:37991299:GGAT:G | donor_gain | 0.6700 |
| X:37990952:A:G | donor_gain | 0.6600 |
| X:37991037:GCGG:G | donor_gain | 0.6600 |
| X:37991068:A:AG | donor_gain | 0.6300 |
| X:37991117:G:GG | donor_gain | 0.6300 |
| X:37990912:C:G | donor_gain | 0.6000 |
| X:37991311:A:AG | donor_gain | 0.6000 |
| X:37990856:ACT:A | donor_gain | 0.5900 |
| X:37991022:T:A | acceptor_gain | 0.5900 |
| X:37990920:C:A | donor_gain | 0.5700 |
| X:37991137:A:AG | donor_gain | 0.5700 |
| X:37991138:G:GG | donor_gain | 0.5700 |
| X:37991164:G:GC | acceptor_gain | 0.5700 |
| X:37990974:GA:G | donor_gain | 0.5600 |
| X:37991036:AGCGG:A | donor_loss | 0.5500 |
| X:37991038:CGGG:C | donor_loss | 0.5500 |
| X:37991039:GGG:G | donor_loss | 0.5500 |
| X:37991041:G:A | donor_loss | 0.5500 |
| X:37991042:T:A | donor_loss | 0.5500 |
| X:37991136:GA:G | donor_gain | 0.5500 |
AlphaMissense
795 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:37991018:T:C | L60P | 0.875 |
| X:37990930:T:C | F31L | 0.867 |
| X:37990932:C:A | F31L | 0.867 |
| X:37990932:C:G | F31L | 0.867 |
| X:37991020:G:C | A61P | 0.810 |
| X:37991009:T:C | L57P | 0.796 |
| X:37991039:G:C | R67P | 0.773 |
| X:37991030:T:G | I64S | 0.752 |
| X:37991053:G:C | A72P | 0.741 |
| X:37991030:T:A | I64N | 0.711 |
| X:37991018:T:A | L60H | 0.688 |
| X:37991030:T:C | I64T | 0.681 |
| X:37991018:T:G | L60R | 0.667 |
| X:37990997:T:C | L53P | 0.666 |
| X:37991009:T:A | L57H | 0.658 |
| X:37991000:T:C | L54P | 0.645 |
| X:37991041:G:C | V68L | 0.623 |
| X:37991041:G:T | V68L | 0.623 |
| X:37991152:T:C | F105L | 0.595 |
| X:37991154:T:A | F105L | 0.595 |
| X:37991154:T:G | F105L | 0.595 |
| X:37991021:C:A | A61D | 0.586 |
| X:37991051:A:G | E71G | 0.583 |
| X:37991051:A:T | E71V | 0.581 |
| X:37991042:T:A | V68E | 0.573 |
| X:37991034:G:A | M65I | 0.564 |
| X:37991034:G:C | M65I | 0.564 |
| X:37991034:G:T | M65I | 0.564 |
dbSNP variants (sampled 300 via entrez): RS1001220367 (X:37990120 C>G,T), RS1001272498 (X:37989908 T>A), RS1001645344 (X:37990274 A>C), RS1003229950 (X:37988909 G>T), RS1005591754 (X:37991412 G>C,T), RS1006213802 (X:37990074 C>T), RS1007460864 (X:37989588 A>G), RS1007675161 (X:37989977 A>G), RS1010034377 (X:37990169 G>A), RS1011503735 (X:37990535 G>A), RS1011864202 (X:37990242 A>G), RS1015992302 (X:37989539 G>A), RS1016934777 (X:37991751 C>T), RS1017275121 (X:37990005 T>C), RS1017400741 (X:37991380 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.